The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Heparanase Enhances Syndecan-1 Shedding
Open accessAbstract
When shed from the cell surface, the heparan sulfate proteoglycan syndecan-1 can facilitate the growth, angiogenesis, and metastasis of tumors. Here we report that tumor cell expression of heparanase, an enzyme known to be a potent promoter of tumor progression and metastasis, regulates both the level and location of syndecan-1 within the tumor microenvironment by enhancing its synthesis and subsequent shedding from the tumor cell surface. Heparanase regulation of syndecan-1 is detected in both human myeloma and breast cancer cell lines. This regulation requires the presence of active enzyme, because mutated forms of heparanase lacking heparan sulfate-degrading activity failed to influence syndecan-1 expression or shedding. Removal of heparan sulfate from the cell surface using bacterial heparitinase dramatically accelerated syndecan-1 shedding, suggesting that the effects of heparanase on syndecan-1 expression by tumor cells may be due, at least in part, to enzymatic removal or reduction in the size of heparan sulfate chains. Animals bearing tumors formed from cells expressing high levels of heparanase or animals transgenic for heparanase expression exhibited elevated levels of serum syndecan-1 as compared with controls, indicating that heparanase regulation of syndecan-1 expression and shedding can occur in vivo and impact cancer progression and perhaps other pathological states. These results reveal a new mechanism by which heparanase promotes an aggressive tumor phenotype and suggests that heparanase and syndecan-1 act synergistically to fine tune the tumor microenvironment and ensure robust tumor growth.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
Self-citationRuhrberg, C., Gerhardt, H., Golding, M., Watson, R., Ioannidou, S., Fujisawa, H., Betsholtz, C., & Shima, D. T. (2002) · Genes & Development · doi:10.1101/gad.242002 · Cited by 914
Li, Q., Park, P. W., Wilson, C. L., & Parks, W. C. (2002) · Cell · doi:10.1016/s0092-8674(02)01079-6 · Cited by 752
Roles of heparan-sulphate glycosaminoglycans in cancer
Sasisekharan, R., Shriver, Z., Venkataraman, G., & Narayanasami, U. (2002) · Nature Reviews Cancer · doi:10.1038/nrc842 · Cited by 621
Regulation, function and clinical significance of heparanase in cancer metastasis and angiogenesis
Ilan, N., Elkin, M., & Vlodavsky, I. (2006) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2006.06.004 · Cited by 524
Self-citationGitay-Goren, H., Soker, S., Vlodavsky, I., & Neufeld, G. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42666-x · Cited by 490
Self-citationKato, M., Wang, H., Kainulainen, V., Fitzgerald, M. L., Ledbetter, S., Ornitz, D. M., & Bernfield, M. (1998) · Nature Medicine · doi:10.1038/nm0698-691 · Cited by 338
Heparanase as mediator of angiogenesis: mode of action
Elkin, M., Ilan, N., Ishai-Michaeli, R., Friedmann, Y., Papo, O., Pecker, I., & Vlodavsky, I. (2001) · The FASEB Journal · doi:10.1096/fj.00-0895fje · Cited by 310
Self-citationVlodavsky, I., Miao, H.-Q., Medalion, B., Danagher, P., & Ron, D. (1996) · Cancer and Metastasis Reviews · doi:10.1007/bf00437470 · Cited by 286
Self-citationCohen, T., Gitay-Goren, H., Sharon, R., Shibuya, M., Halaban, R., Levi, B.-Z., & Neufeld, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.19.11322 · Cited by 269
Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence
Park, P. W., Pier, G. B., Hinkes, M. T., & Bernfield, M. (2001) · Nature · doi:10.1038/35075100 · Cited by 243
Zcharia, E., Metzger, S., Chajek‐Shaul, T., Aingorn, H., Elkin, M., Friedmann, Y., Weinstein, T., Li, J., Lindahl, U., & Vlodavsky, I. (2004) · The FASEB Journal · doi:10.1096/fj.03-0572com · Cited by 242
Self-citationSerum syndecan-1: a new independent prognostic marker in multiple myeloma
Seidel, C., Sundan, A., Hjorth, M., Turesson, I., Dahl, I. M. S., Abildgaard, N., Waage, A., & Børset, M. (2000) · Blood · doi:10.1182/blood.v95.2.388 · Cited by 239
Zetser, A., Bashenko, Y., Edovitsky, E., Levy-Adam, F., Vlodavsky, I., & Ilan, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1811 · Cited by 234
Self-citationHeparanase Induces Endothelial Cell Migration via Protein Kinase B/Akt Activation
Gingis-Velitski, S., Zetser, A., Flugelman, M. Y., Vlodavsky, I., & Ilan, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400554200 · Cited by 220
Self-citationBendre, M. S., Gaddy-Kurten, D., Mon-Foote, T., Akel, N. S., Skinner, R. A., Nicholas, R. W., & Suva, L. J. (2002) · PubMed · Cited by 212
Soluble syndecan-1 promotes growth of myeloma tumors in vivo
Yang, Y., Yaccoby, S., Liu, W., Langford, J. K., Pumphrey, C. Y., Theus, A., Epstein, J., & Sanderson, R. D. (2002) · Blood · doi:10.1182/blood.v100.2.610 · Cited by 190
Self-citationHeparan sulfate proteoglycans and heparanase—partners in osteolytic tumor growth and metastasis
Sanderson, R. D., Yang, Y., Suva, L. J., & Kelly, T. (2004) · Matrix Biology · doi:10.1016/j.matbio.2004.08.004 · Cited by 189
Self-citationGlypican-1 Is a VEGF165 Binding Proteoglycan That Acts as an Extracellular Chaperone for VEGF165
Gengrinovitch, S., Berman, B., David, G., Witte, L., Neufeld, G., & Ron, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10816 · Cited by 182
Li, J.-P., Galvis, M. L. E., Gong, F., Zhang, X., Zcharia, E., Metzger, S., Vlodavsky, I., Kisilevsky, R., & Lindahl, U. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0502287102 · Cited by 180
Self-citationHeparanase mediates cell adhesion independent of its enzymatic activity
GOLDSHMIDT, O., ZCHARIA, E., COHEN, M., AINGORN, H., COHEN, I., NADAV, L., KATZ, B.-Z., GEIGER, B., & VLODAVSKY, I. (2003) · The FASEB Journal · doi:10.1096/fj.02-0773com · Cited by 176
Self-citationHigh heparanase activity in multiple myeloma is associated with elevated microvessel density.
Kelly, T. J., Miao, H., Yang, Y., Navarro, E. C., Kussie, P. H., Huang, Y., MacLeod, V., Casciano, J., Joseph, L., Zhan, F., et al. (2003) · PubMed · Cited by 166
Self-citationIdentification of Active-Site Residues of the Pro-Metastatic Endoglycosidase Heparanase
Hulett, M. D., Hornby, J. R., Ohms, S., Zuegg, J., Freeman, C. G., Gready, J. E., & Parish, C. R. (2000) · Biochemistry · doi:10.1021/bi002080p · Cited by 152
Sanderson, R. D., Yang, Y., Kelly, T. J., MacLeod, V., Dai, Y., & Theus, A. M. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20602 · Cited by 148
Self-citationHeparanase promotes the spontaneous metastasis of myeloma cells to bone
Yang, Y., MacLeod, V., Bendre, M. S., Huang, Y., Theus, A. M., Miao, H., Kussie, P. H., Yaccoby, S., Epstein, J., Suva, L. J., et al. (2004) · Blood · doi:10.1182/blood-2004-06-2141 · Cited by 134
Self-citationBørset, M., Hjertner, Ø., Yaccoby, S., Epstein, J., & Sanderson, R. D. (2000) · Blood · doi:10.1182/blood.v96.7.2528 · Cited by 121
Self-citationDhodapkar, M. V., Kelly, T. J., Theus, A. M., Athota, A. B., Barlogie, B., & Sanderson, R. D. (1997) · British Journal of Haematology · doi:10.1046/j.1365-2141.1997.3893203.x · Cited by 100
Self-citationIdentification of a Heparin Binding Peptide on the Extracellular Domain of the KDR VEGF Receptor
Dougher, A. M., Wasserstrom, H. A., Torley, L. W., Shridaran, L., Westdock, P., Hileman, R. E., Fromm, J. R., Anderberg, R. J., Lyman, S. D., Linhardt, R. J., et al. (1997) · Growth Factors · doi:10.3109/08977199709021524 · Cited by 95
Syndecan-1 in B lymphoid malignancies
Sanderson, R. D., & Børset, M. (2002) · Annals of Hematology · doi:10.1007/s00277-002-0437-8 · Cited by 80
Self-citationHeparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass
Kram, V., Zcharia, E., Yacoby‐Zeevi, O., Metzger, S., Chajek‐Shaul, T., Gabet, Y., Müller, R., Vlodavsky, I., & Bab, I. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20625 · Cited by 60
Self-citationHeparanase Regulates Murine Hair Growth
Zcharia, E., Philp, D., Edovitsky, E., Aingorn, H., Metzger, S., Kleinman, H. K., Vlodavsky, I., & Elkin, M. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62321-8 · Cited by 56
Self-citationChiang, M., & Flanagan, J. G. (1995) · Growth Factors · doi:10.3109/08977199509003208 · Cited by 50
Cited by
Proteoglycan form and function: A comprehensive nomenclature of proteoglycans
Iozzo, R. V., & Schaefer, L. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.02.003 · Cited by 1,263
Yuan, Z., Li, Y., Zhang, S., Wang, X., Dou, H., Yu, X., Zhang, Z., Yang, S., & Xiao, M. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01744-8 · Cited by 977
Understanding multiple myeloma pathogenesis in the bone marrow to identify new therapeutic targets
Hideshima, T., Mitsiades, C., Tonon, G., Richardson, P. G., & Anderson, K. C. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2189 · Cited by 932
Proteoglycans in cancer biology, tumour microenvironment and angiogenesis
Iozzo, R. V., & Sanderson, R. D. (2011) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01236.x · Cited by 569
Self-citationThe extracellular matrix in breast cancer
Insua-Rodríguez, J., & Oskarsson, T. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.12.017 · Cited by 470
Metadata
- Authors
- Yang, Y., MacLeod, V., Miao, H.-Q., Theus, A., Zhan, F., Shaughnessy, J. D., Sawyer, J., Li, J.-P., Zcharia, E., Vlodavsky, I., & Sanderson, R. D.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 282
- Issue
- 18
- Pages
- 13326-13333
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1977877980
- Cited by
- 264
- References
- 32
- FWCI
- 8.18
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.